Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals Crinetics Pharmaceuticals — Operating loss by Year
Crinetics Pharmaceuticals — Operating loss ($M) ($M)
Vertex Pharmaceuticals Crinetics Pharmaceuticals — Operating loss: -$517M in FY2025, up 52.5% from a year earlier. That is the lowest of the 8 years on record here.
Where the FY2025 figure comes from
Source: SEC Filing ↗
Reported in SEC XBRL (CIK 0001699813 Crinetics Pharmaceuticals).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Crinetics Pharmaceuticals — Operating loss ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | -517 | +52.5% | SEC Filing ↗ |
| FY2024 | Dec 31, 2024 | -339 | +52.2% | SEC Filing ↗ |
| FY2023 | Dec 31, 2023 | -223 | +32.6% | SEC Filing ↗ |
| FY2022 | Dec 31, 2022 | -168 | +55.9% | SEC Filing ↗ |
| FY2021 | Dec 31, 2021 | -108 | +43.7% | SEC Filing ↗ |
| FY2020 | Dec 31, 2020 | -75.0 | +39.2% | SEC Filing ↗ |
| FY2019 | Dec 31, 2019 | -53.8 | +87.5% | SEC Filing ↗ |
| FY2018 | Dec 31, 2018 | -28.7 | – | SEC Filing ↗ |
Cite this data
StockData. (2026). Vertex Pharmaceuticals Crinetics Pharmaceuticals — Operating loss ($M), annual FY2018–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/crinetics-op-inc
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.